Laurence J. Blumberg
Founder at Syntimmune, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Paul Kress | M | 59 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | 6 years |
| Seth Harrison | M | 63 |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | - |
| Richard S. Blumberg | M | - |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | 11 years |
| Louis Blumberg | M | 92 |
AFB Fund LLC
 AFB Fund LLC Investment Trusts/Mutual FundsMiscellaneous AFB Fund LLC provides fund and sub-fund services. It offers general, designated, restricted and auxiliary fund services. The company is headquartered in Tenafly, NJ. | 47 years |
| John McKearn | M | 70 |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
| Elizabeth J. Keefer | F | - |
The Trustees of Columbia University in The City of New York
| 27 years |
| Michel Ducreux | M | - |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
| Beth Devine | M | - |
Blumberg Capital Advisors LLC
| 7 years |
| Eric Pham | M | - |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
| Kyle Rasbach | M | - |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
| Ronald A. Krasnow | M | 61 |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 4 years |
| Bobby Sandage | M | 70 |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
| Joe Biller | M | - |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
| Phillip A. Bauman | M | 67 |
The Trustees of Columbia University in The City of New York
| 27 years |
| Robert Hubbard | M | 66 |
The Trustees of Columbia University in The City of New York
| 27 years |
| Paul D. Sonkin | M | 56 |
The Trustees of Columbia University in The City of New York
| 26 years |
| Carole Nüchterlein | F | 62 |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | 8 years |
| Sabin C. Streeter | M | 82 |
The Trustees of Columbia University in The City of New York
| 27 years |
| Ellen Oran Kaden | F | 72 |
The Trustees of Columbia University in The City of New York
| 28 years |
| Joyce O'Shaughnessy | F | - |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vincenzo LiCausi | M | 50 | 7 years | |
| David de Graaf | M | - |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | - |
| Heydon Traub | M | - |
Brandeis University
| 6 years |
| Ari H. Shrage | M | - |
The Trustees of Columbia University in The City of New York
| 6 years |
| Anil Patel | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Andrea L. Nicolas | M | - |
The Trustees of Columbia University in The City of New York
| 6 years |
| David Ham | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Justin Lu | M | 53 |
The Trustees of Columbia University in The City of New York
| 3 years |
| David Joseph Austerweil | M | - |
The Trustees of Columbia University in The City of New York
| 8 years |
| David Carter | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Sherri Scribner | F | - |
The Trustees of Columbia University in The City of New York
| 6 years |
| Saurin Dinesh Shah | M | 57 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Henry Lu | M | 58 |
The Trustees of Columbia University in The City of New York
| 6 years |
| Ehud A. Gelblum | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Steven Gutterman | M | 55 |
The Trustees of Columbia University in The City of New York
| 5 years |
| Hank L. Torbert | M | 52 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Ming Yeung Lau | M | 45 |
The Trustees of Columbia University in The City of New York
| 5 years |
| James Stone | M | - |
The Trustees of Columbia University in The City of New York
| 10 years |
| John F. McGuire | M | 77 | 7 years | |
| David Chazanovitz | M | 72 | 6 years | |
| Yi Ping Wang | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Roderick de Greef | M | 63 | 2 years | |
| Margaret Furay Fay | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Andrew Fabens | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Netta Samroengraja | F | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Christian Melander | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Matthew B. Chaldecott | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| David Seth Rich | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| David Woo | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Christopher F. Tirotta | M | 64 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Harvey Schwartz | M | 60 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Michael Feldman | M | 50 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Vikas Mavinkurve | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Charles Ho | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Lily L. Parshall | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Ari Jay Storch | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Adam Lesser | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Aleem A. Mawji | M | 50 |
The Trustees of Columbia University in The City of New York
| 4 years |
| David Christopher Gray | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Stephanie Sirota | F | 49 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Jin Liu | M | 54 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Kirby Joel Mack | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Holly Ruxin | F | 54 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Shazim Chhapra | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Rick Biggs | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Yongbai Choi | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Edgar A. Buttner | M | 61 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Ethan A. Falkove | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Phillip Ahn | M | 54 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Robert W. Liptak | M | 60 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Avi Zolaikhaian Berg | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Brian Pessin | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Joshua Woolston Fenton | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Stephen Bondi | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| John Rodin | M | 48 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Miles A. Wixon | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Robert Hazlett | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Richard Cohen | M | - |
The Trustees of Columbia University in The City of New York
| - |
| Jeff Cino | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Brian Goodstadt | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Kevin Lynch | M | 55 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Susan Buchsbaum Hutman | F | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Andrew James Tompsett Newington | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Sophie Lombard | F | 53 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Ion Yadigaroglu | M | 54 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Christian Cortis | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Eric M. Jackson | M | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Jeff Hoerle | M | 57 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Scott Ostfeld | M | 47 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Laing Rikkers | F | 54 |
The Trustees of Columbia University in The City of New York
| 5 years |
| Seth B. Weinberg | M | 50 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Richard T. Spencer | M | 87 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Timothy Rosenzweig | M | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Jonathan Costello | M | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Leland Gershell | M | 52 |
The Trustees of Columbia University in The City of New York
| 4 years |
| Gary Nackenson | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Perry Jung | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| Song Zuo Xiang | M | 59 |
The Trustees of Columbia University in The City of New York
| 1 years |
| Andrew Byington | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Rick de los Reyes | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Laurence J. Blumberg
- Personal Network
